Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$1.06 - $1.97 $3,481 - $6,469
-3,284 Reduced 8.53%
35,216 $39,000
Q4 2022

Feb 02, 2023

BUY
$1.4 - $25.4 $8,848 - $160,528
6,320 Added 19.64%
38,500 $56,000
Q3 2022

Nov 04, 2022

SELL
$0.36 - $36.0 $221 - $22,140
-615 Reduced 1.88%
32,180 $59,000
Q2 2022

Aug 01, 2022

SELL
$12.3 - $27.3 $268,939 - $596,914
-21,865 Reduced 40.0%
32,795 $45,000
Q1 2022

May 10, 2022

SELL
$16.6 - $32.3 $150,777 - $293,380
-9,083 Reduced 14.25%
54,660 $141,000
Q4 2021

Feb 08, 2022

BUY
$29.9 - $61.2 $828,020 - $1.69 Million
27,693 Added 76.82%
63,743 $191,000
Q3 2021

Nov 12, 2021

SELL
$51.4 - $68.2 $1.9 Million - $2.52 Million
-36,927 Reduced 50.6%
36,050 $198,000
Q2 2021

Aug 13, 2021

BUY
$44.1 - $84.0 $3.22 Million - $6.13 Million
72,977 New
72,977 $535,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $63.8M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.